Celgene acquires autoimmune startup Delinia for $300M+

Celgene acquires autoimmune startup Delinia for $300M+

Celgene bought the startup for $300 million upfront to expand its inflammation and immunology pipeline with Delinia's regulatory T cell therapy.

Novartis invests in, partners with Perlara

Novartis invests in, partners with Perlara

Novartis invested and partnered with Perlara, a resident of QB3@953, to discover and develop treatments for lysosomal storage disorders using CRISPR-engineered animal models.

Meet Trace Genomics, The "23andMe" Of Soil

Meet Trace Genomics, The "23andMe" Of Soil

For $199, farmers can understand their soil better—which is key to keeping their crops healthy.

FierceBiotech Names Atreca as One of Its “Fierce 15” Biotech Companies of 2016

 FierceBiotech Names Atreca as One of Its “Fierce 15” Biotech Companies of 2016

The honor designates Atreca as one of the most promising private biotechnology companies in the industry.

Delinia Announces $35 Million Series A Financing to Advance Novel Therapeutics Targeting Regulatory T Cells for Autoimmune Diseases

Delinia Announces $35 Million Series A Financing to Advance Novel Therapeutics Targeting Regulatory T Cells for Autoimmune Diseases

The company will develop new medicines to selectively potentiate and expand regulatory T cells.

Circle Pharma Enters into an Agreement with Pfizer to Build Screening Library of Macrocyclic Peptides

Circle Pharma Enters into an Agreement with Pfizer to Build Screening Library of Macrocyclic Peptides

Pfizer will support Circle as the startup uses computational design and synthetic chemistry to build a library of macrocyclic peptides.

Mayo Adds To Its List Of Gut Microbiome Startup Collaborators

Mayo Adds To Its List Of Gut Microbiome Startup Collaborators

The Mayo Institute and Whole Biome are collaborating to decrease rates of preterm birth and labor.